|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocn646822767 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
100712s2009 enkaf ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d YDXCP
|d IDEBK
|d DKU
|d OCLCQ
|d OCLCF
|d OCLCQ
|d LND
|d VT2
|d OCLCQ
|d WYU
|d OCLCQ
|d UX1
|d OCLCO
|d OCLCQ
|d INARC
|d OCLCO
|d OCLCQ
|d OCLCL
|
016 |
7 |
|
|a 101490370
|2 DNLM
|
019 |
|
|
|a 528505611
|a 1101715799
|
020 |
|
|
|a 9780470092569
|q (electronic bk.)
|
020 |
|
|
|a 0470092564
|q (electronic bk.)
|
020 |
|
|
|a 0470092548
|q (HB)
|
020 |
|
|
|a 0470092556
|q (PB)
|
020 |
|
|
|a 9780470092545
|q (HB)
|
020 |
|
|
|a 9780470092552
|q (PB)
|
024 |
8 |
|
|a 9786612112171
|
029 |
1 |
|
|a AU@
|b 000052978372
|
029 |
1 |
|
|a AU@
|b 000062469482
|
035 |
|
|
|a (OCoLC)646822767
|z (OCoLC)528505611
|z (OCoLC)1101715799
|
050 |
|
4 |
|a RC271.C5
|b A35 2009eb
|
060 |
|
4 |
|a 2009 E-866
|
060 |
|
4 |
|a QZ 267
|b A298c 2009
|
072 |
|
7 |
|a MED
|x 062000
|2 bisacsh
|
072 |
|
7 |
|a HEA
|x 039030
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99/4061
|2 22
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Airley, Rachel.
|
245 |
1 |
0 |
|a Cancer chemotherapy /
|c Rachel Airley.
|
260 |
|
|
|a Chichester, UK ;
|a Hoboken, NJ :
|b Wiley-Blackwell,
|c 2009.
|
300 |
|
|
|a 1 online resource (x, 341 pages, 8 unnumbered pages of plates) :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references (pages 299-330) and index.
|
505 |
0 |
|
|a Cancer epidemiology -- Histopathology of cancer -- Carcinogenesis, malignant transformation, and progression -- Molecular biology of cancer : oncogenes and tumour suppressor genes -- Tumour metastasis : a convergence of many theories -- Health professionals in the treatment of cancer -- Principles of cancer chemotherapy -- Classic anticancer agents -- The philosophy of cancer research -- Novel anticancer agents -- Clinical trials -- Tumour hypoxia -- Antiangiogenic and antivascular agents -- Tyrosine kinase inhibitors -- Ras inhibitors -- Inhibitors of the Akt/PKB pathway -- Targeting stress proteins: HSP90 inhibitors -- The proteasome -- Checkpoint protein kinases as novel targets : mammalian target of rapamycin (mTOR) -- Telomerase -- Histone deacetylase : an epigenetic drug target -- Pharmaceutical problems in cancer chemotherapy -- Oncology pharmacy at home and abroad -- Practice exam questions.
|
520 |
8 |
|
|a This text offers a useful resource for all students taking courses in the subject. It enables the student to gain an understanding of the pathological, physiological & molecular processes governing malignancy, whilst also introducing the role of health professionals and scientists in the research and treatment of cancer.
|
588 |
0 |
|
|a Print version record.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Cancer
|x Chemotherapy.
|
650 |
1 |
2 |
|a Neoplasms
|x drug therapy
|
650 |
2 |
2 |
|a Antineoplastic Agents
|x therapeutic use
|
650 |
|
6 |
|a Cancer
|x Chimiothérapie.
|
650 |
|
7 |
|a MEDICAL
|x Oncology.
|2 bisacsh
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Cancer.
|2 bisacsh
|
650 |
|
7 |
|a Cancer
|x Chemotherapy
|2 fast
|
650 |
|
7 |
|a Tumeurs
|x traitement médicamenteux.
|2 fmesh
|
650 |
|
7 |
|a Cancer
|x Chimiothérapie.
|2 ram
|
758 |
|
|
|i has work:
|a Cancer chemotherapy (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFQGr4kQYHrFTJPmfPBCYq
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Airley, Rachel.
|t Cancer chemotherapy.
|d Chichester, UK ; Hoboken, NJ : Wiley-Blackwell, 2009
|z 9780470092552
|w (DLC) 2008052079
|w (OCoLC)216941051
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=427919
|z Texto completo
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 274731
|
938 |
|
|
|a Internet Archive
|b INAR
|n cancerchemothera0000airl
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 3047549
|
994 |
|
|
|a 92
|b IZTAP
|